Granules India posts Q2 net profit at Rs 40 crore
New Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current fiscal.
The company had posted a net profit of Rs 40.82 crore during the same period of the previous fiscal, Granules India said in a regulatory filing.
Total income during the quarter under review stood at Rs 399.39 crore as against Rs 367.68 crore in the July-September quarter of the last fiscal.
"As our emerging business is taking shape to drive future business growth, our core business continues to deliver sustainable revenues," Granules India CMD Krishna Prasad Chigurupati said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd